Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study.
Alba C, Malhotra S, Horsfall S, Barnhart ME, Bekker A, Chapman K, Cunningham CK, Fast PE, Fouda GG, Freedberg KA, Goga A, Ghazaryan LR, Leroy V, Mann C, McCluskey MM, McFarland EJ, Muturi-Kioi V, Permar SR, Shapiro R, Sok D, Stranix-Chibanda L, Weinstein MC, Ciaranello AL, Dugdale CM.
Alba C, et al. Among authors: horsfall s.
medRxiv [Preprint]. 2023 Nov 7:2023.11.06.23298184. doi: 10.1101/2023.11.06.23298184.
medRxiv. 2023.
PMID: 37986879
Free PMC article.
Preprint.